← All trials
NCT07218003
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 30, 2025
- Primary completion
- Feb 28, 2029
- Completion date
- Mar 31, 2029
- First posted
- Oct 17, 2025
- Last posted
- Oct 24, 2025
- Enrollment
- 149
- Arms / groups
- 15 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Rondo TherapeuticsLead sponsor
- Rondo TherapeuticsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.